The global pain management drugs market is anticipated to grow at a CAGR of 3.88% between 2019 and 2027. Rise in geriatric population is the major factor that drives the growth of the global pain management market, as aged people are more prone to suffer from joint pain and other chronic conditions. The following factors are primarily driving the pain management drugs market:

• Growth in the incidence and prevalence of chronic diseases
• The rise in awareness regarding the side-effects of pain medication
• Rise in geriatric population size

The important drivers increasing growth in the global pain management drugs market are the increasing occurrences of chronic diseases and rise in the geriatric population. The higher the chronic diseases occur, such as heart disease, stroke, type II diabetes, and cancer, the higher will be the sales of the said market for its product which will furthermore drive the pain management drugs market growth. The rise in geriatric population could also increase the usage of pain medications, thus, boosting the market growth.

The drug class of pain management drugs market is mainly employed for pain management treatment. The growing demand for NSAIDs has led to an increase in the emergence of new products in the market that uses NSAID components. An anesthetic is a drug used to prevent the feeling of pain during surgery. Anticonvulsants are used extensively for the treatment of fibromyalgia, migraine and neuropathic pain. An antimigraine drug is a medication designed to reduce the effects or intensity of a migraine headache. Antidepressants could be used to treat pain caused by a migraine, arthritis, low back pain, peripheral neuropathy and others. Opioids are narcotic drugs and mostly indicated for the pain management. The drugs act on both the central nervous system and peripheral nervous system. The opioid drugs are associated with several side effects such as mental fog, drowsiness, constipation and nausea. Non-narcotic analgesics are used to treat persistent or acute pains. They are mainly used for the treatment of mild to moderate pain; however, these drugs can be used in combination with other medications or therapies to treat moderate to severe pain.

Accessibility of alternative therapies and an increase in drug mistreatment are the major factors hindering the progress of the pain management drugs market. Alternative therapies are gaining popularity in recent times as they cause fewer side-effects and more effective at alleviating pain as compared to drugs. Increase in drug mistreatment has increased the stringency of regulatory authorities for the development of drugs.

The global pain management drugs market segments include drug class and indication.

Drug class is segmented into:

• Anesthetics
• Opioids
• Anticonvulsants
• NSAIDs
• Antidepressants
• Anti-migraine agents
• Non-narcotic analgesics

Indication is segmented into:

• Fibromyalgia
• Neuropathic pain
• Cancer pain
• Arthritic pain
• Post-operative pain
• Migraine
• Chronic back pain

This report covered the present market conditions and the growth prospects of the global pain management drugs market for 2019-2027 and considered the revenue generated through the sales of pain management drugs for the segments of drug class and indication to calculate the market size by considering 2018 as the base year.

Geographically, the global pain management drugs market has been segmented into four major regions, which include:

• North America: The United States & Canada
• Asia-Pacific: China, India, Japan, Australia, South Korea & Rest of APAC
• Europe: The United Kingdom, France, Germany, Italy, Spain & Rest of Europe
• Rest of World: Latin America & the Middle East and Africa

The pain management drugs market in North America is expected to hold the largest share by 2027 because of major possibilities of the rising frequency of drug abuse cases. The addictive nature of opioids has also decreased the use of opioid as a prescription drug in the North American region, leading to a decline in opioid consumption as medicine in this region for pain management. The presence of a large patient population suffering from pain also boosted the market growth. The rate of a drug overdose has been increased in Canada, coincidently due to the higher prescription rate of opioid drugs that is furthermore driving the market growth for pain management market.

On the other hand, the Asia-Pacific market is anticipated to be the fastest-growing region for the pain management drugs market. This is mainly attributable to the presence of a larger patient pool and the increase in healthcare expenditure in this region. Japan is the largest contributor towards the Asia-Pacific market. China and India are among the fastest growing pain management drugs markets in the region.

The pain management drugs market is segmented on the basis of indication which is sub-divided into neuropathic pain, migraine, chronic back pain, cancer pain, arthritic pain, post-operative pain and fibromyalgia. Problems associated with aches and pain caused in joints are occurring mainly because of arthritis. Neuropathic pain is usually caused due to damage or disease that affects the somatosensory nervous system. Cancer pain is frequently caused by the tumorous tissue growth in the bones, nerves or other organs in the body. Due to the growing demand of remedies for chronic backaches, there is an increase in the governmental support to speed up the approval process for medications and provide help to patients with improved prescription drugs. Post-operative pain is usually caused after the patient undergoes through some form of surgeries. A migraine is a type of headache-related malady with sensitivity towards odor, light or acoustics. Fibromyalgia is a common type of chronic pain where the patient suffers from musculoskeletal pain along with memory, fatigue, sleep and mood issues.

The major market players of the global pain management drugs market are:

• Pfizer, Inc.
• Purdue Pharma L.P.
• Eli Lilly And Company
• GlaxoSmithKline
• Johnson & Johnson

Company Profiles covers analysis of important players.

Pfizer, Inc. is engaged in the discovery, development and manufacture of healthcare products. Its global portfolio includes medicines and vaccines as well as consumer healthcare products. Johnson & Johnson conducts its international business through more than 250 operating companies across the globe. It has major operations in the Americas, Europe, Asia Pacific and Africa.

Key findings of the global pain management drugs market:

• Opioids market holds the largest market share in terms of the drug class
• Cancer pain indication is anticipated to grow at a significant rate